TRACON Pharmaceuticals competitorsClear all

TRACON Pharmaceuticals's top competitors include Northwest Biotherapeutics, Merrimack Pharmaceuticals, CytomX Therapeutics and Clovis Oncology.
TRACON Pharmaceuticals
TRACON Pharmaceuticals
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Clovis Oncology
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Founding Date
Founding Date
2006
Founding Date
1998
Founding Date
2000
Founding Date
2008
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Locations
Boulder, US HQ
Paris, FR
München, DE
Milano, IT
Madrid, ES
Zürich, CH
see more
Employees
Employees
268% increase
Employees
1721% increase
Employees
2763% decrease
Employees
15815% increase
Employees
4843% increase
Valuation ($)
Valuation ($)
127.2 m
Valuation ($)
1.1 b
Valuation ($)
88 m
Valuation ($)
495.6 m
Valuation ($)
583.3 m
Twitter followers
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
1.1 k
Twitter followers
908
Twitter followers
936
Alexa Website Rank
Alexa Website Rank
163545
Alexa Website Rank
189256
Alexa Website Rank
221397
Alexa Website Rank
286453
Alexa Website Rank
238416
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
3.4
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$100.4m (FY, 2020)
Revenue (est.)
$164.5m (FY, 2020)
Net income
Net income
($16.8m) (FY, 2020)
Net income
($20.3m) (FY, 2019)
Net income
($17.3m) (FY, 2019)
Net income
($32.9m) (FY, 2020)
Net income
($369.2m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 41m
Total funding raised
$ 135.9m
Total funding raised
$ 79.4m
Total funding raised
$ 132.4m
Total funding raised
$ 357m
For sources of this data, please see the company profile

View company profiles

Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company